Abstract:The newly identified pyroglutamylated RFamide peptide (QRFP) signaling system has been shown to be implicated in regulating a variety of physiological processes. G-protein-coupled receptors (GPCRs) are preferentially N-glycosylated on extracellular domains. The human QRFP receptor QRFPR (GPR103) possesses three N-glycosylation consensus sites, two located on the N-terminal domain (N5 and N19) and one on the first extracellular loop (ECL1) (N106); however, to date, their role in QRFPR expression and signaling has not been established. Here, we combined mutants with glutamine substitution of the critical asparagines of the consensus sites with glycosidase PNGase F and N-glycosylation inhibitor tunicamycin to study the effect of N-glycosylation in the regulation of QRFPR cell surface expression and signaling. Western blot analysis performed with site-directed mutagenesis revealed that two asparagines at N19 in the N-terminus and N106 in ECL1, but not N5 in the N-terminus, served as sites for N-glycosylation. Treatment with PNGase F and tunicamycin resulted in a reduction in both two-protein species, similar to 43 kDa and similar to 85 kDa in size, by 2-4 kDa. Analysis with confocal microscopy and quantitative ELISA showed that N-glycosylation of QRFPR is not essentially required for targeting the cell membrane. However, further binding assay and functional assays demonstrated that removal of N-glycosylation sequons or treatment with tunicamycin led to significant impairments in the interaction of receptor with QRFP26 and downstream signaling. Thus, our findings suggest that for the human QRFP receptor (QRFPR), N-glycosylation is not important for cell surface expression but is a pre-requisite for ligand binding and receptor activation.

Structural basis for recognition of 26RFa by the pyroglutamylated RFamide peptide receptor

Structure and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103

N-glycosylation of the human neuropeptide QRFP receptor (QRFPR) is essential for ligand binding and receptor activation

Molecular mechanism of prolactin-releasing peptide recognition and signaling via its G protein-coupled receptor

Structure and Drug Development of the Human Formylpeptide Receptors FPR1 and FPR2.

Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors

Structural basis for signal recognition and transduction by platelet-activating-factor receptor

Structural basis for ligand recognition of the neuropeptide Y Y2 receptor

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Structural Basis of Neuropeptide Y Signaling Through Y1 and Y2 Receptors

[Single-Particle Cryo-Electron Microscopy Opens New Avenues in Structural Biology of G Protein-Coupled Receptor].

Phase-plate Cryo-Em Structure of a Class B GPCR–G-protein Complex

Molecular Recognition of an Acyl-Peptide Hormone and Activation of Ghrelin Receptor

Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns

Structure of Formylpeptide Receptor 2-Gi Complex Reveals Insights into Ligand Recognition and Signaling

Structural basis of peptide recognition and activation of endothelin receptors

Structural Perspective on Ancient Neuropeptide Y-like System reveals Hallmark Features for Peptide Recognition and Receptor Activation

Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors

Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84